Faithward Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.53M | Buy |
14,429
+663
| +5% | +$70.4K | 0.24% | 86 |
|
2025
Q1 | $1.71M | Sell |
13,766
-557
| -4% | -$69.2K | 0.3% | 80 |
|
2024
Q4 | $1.76M | Buy |
14,323
+460
| +3% | +$56.6K | 0.3% | 80 |
|
2024
Q3 | $1.54M | Sell |
13,863
-257
| -2% | -$28.6K | 0.27% | 90 |
|
2024
Q2 | $1.51M | Buy |
14,120
+261
| +2% | +$27.9K | 0.27% | 89 |
|
2024
Q1 | $1.67M | Buy |
13,859
+165
| +1% | +$19.9K | 0.3% | 77 |
|
2023
Q4 | $1.67M | Buy |
13,694
+2,780
| +25% | +$339K | 0.37% | 65 |
|
2023
Q3 | $1.33M | Buy |
+10,914
| New | +$1.33M | 0.32% | 67 |
|